C
Metabolic dysfunction
11
evidence score
Also known as: metabolic functions
PREVENT status
Not a PREVENT input variable.
Causal support
trial evidence
Score components
lit volume: 3meta-analyses: 0trials: 7.8genetic: 0MR bonus:
References (1)
0 meta-analyses / systematic reviews- Psychosocial and biobehavioral factors and their interplay in coronary heart disease. — Annual review of clinical psychology 2008 · PMID 17716037
Clinical trials (5)
| NCT | Title | Status | Type | Interventions |
|---|---|---|---|---|
| NCT07585526 | Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease. A Randomized Control Trial. | NOT YET RECRUITING | INTERVENTIONAL | Finerenone, Spironolactone, Standard Medical Treatment |
| NCT07391267 | Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide - a Randomized Controlled Trial. | NOT YET RECRUITING | INTERVENTIONAL | Semaglutide Oral Tablet, Placebo, Standard medical treatment |
| NCT06117137 | The Impact Of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Dysfunction -Associated Steatotic Liver Disease In Patients With Type 2 Diabetes Mellitus | COMPLETED | INTERVENTIONAL | SGLT2 inhibitor |
| NCT07539584 | Adiponectin and Its Role in the Treatment of Patients With Metabolic Disorders | COMPLETED | INTERVENTIONAL | SGLT2 inhibitor, GLP-1 RA |
| NCT02819440 | PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction | COMPLETED | INTERVENTIONAL | Tadalafil, Placebo |
Genetic associations (0)
None linked.